Brenda S Critz

Title: The Innovations of Brenda S Critz

Introduction

Brenda S Critz is a notable inventor based in Frederick, MD (US). She has made significant contributions to the field of genetics, particularly in relation to the BRCA1 gene. With a total of 4 patents, her work has implications for breast and ovarian cancer research and treatment.

Latest Patents

Critz's latest patents focus on the coding sequences of the human BRCA1 gene. These inventions are directed to three specific coding sequences of the BRCA1 gene, which include BRCA1.sup.(omi1), BRCA1.sup.(omi2), and BRCA1.sup.(omi3). The patents provide information on their frequencies of occurrence along with the protein sequences they code for. Additionally, her inventions encompass methods for determining the consensus sequence for any gene and identifying individuals with an increased genetic susceptibility to breast or ovarian cancer due to inherited mutations in their BRCA1 gene. Furthermore, her work includes methods for performing gene therapy and protein therapy using the isolated BRCA1 coding sequences and their functional equivalents.

Career Highlights

Throughout her career, Brenda S Critz has worked with various companies, including Oncormed, Inc. and Gene Logic, Inc. Her expertise in genetics and innovation has positioned her as a key figure in her field.

Collaborations

Critz has collaborated with notable coworkers such as Patricia D Murphy and Antonette C Allen, contributing to advancements in genetic research and therapy.

Conclusion

Brenda S Critz's contributions to the field of genetics, particularly through her patents related to the BRCA1 gene, highlight her role as an influential inventor. Her work continues to impact cancer research and treatment methodologies.